ArticleStroke (Hoboken, N.J.)2025
(Holo-Stroke-CTA): Stroke Hologram Teleportation for CTA Large Vessel Occlusion Assessments.
Article in Stroke (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- (Holo-PACS): use of holograms to improve provider acumen when reading clinical radiographic scans.Neurological research · 2026Article
- Holo-Stroke-ii: Stroke care through stroke hologram teleportation- inpatient immersion.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Background: Augmented Reality (AR) enables visualization of and interaction with both physical and virtual environments. Holograms can allow 3D image transmission to distant sites, allowing patients to interact with providers as if in the same space. Our prior publication resulted in high satisfaction/immersion for patients interacting with Holo-Stroke providers. Our aim here was to determine if providers assessing CTAs for large vessel occlusion (LVO) would result in reliability and satisfaction. Methods: Thirty-six head CTAs were de-identified and scored by Stroke Faculty, Fellows, and Nurse Practitioners for LVO using DICOM viewer. CTAs were presented 2 months later via Holo-Stroke. Holograms were positioned in 3D-space, viewable through the Hololens-2, and scored by the same providers. Kappa Reliability was assessed comparing scores to gold-standard (radiology report). Satisfaction was assessed via Likert scale. Results: Thirteen providers scored the CTAs. Overall Kappa reliability, compared to gold standard, was 0.78(81%)DICOMvs.0.94(94%)Holo-Stroke-CTA(p<0.0001). Overall %correct was 81%vs.94%(p<0.001). Holo-Stroke-CTA's reliability improved for most examiners: Overall (κ=0.78(81%)vs.0.94(94%)), Faculty (κ=0.85(87%)vs.0.92(93%)), NPs (κ=0.81(83%)vs.0.90(92%)), and Fellows (κ=0.68(72%)vs.0.97(97%)). Overall MCA (κ=0.76(86%)vs.0.93(96%)), ICA (κ=0.8(88%)vs.0.9(94%)), and Basilar (κ=0.73(95%)vs. 0.82(96%)) scored high, with marked improvement for ACA (κ=0.3(39%)vs. 0.91(94%)), and PCA (κ=0.55(70%)vs.0.95(98%)). Likert satisfaction "Overall" was (18DICOM,48Holo-Stroke-CTA;p=0.002) with %increasing from 39% to 96%. "Immersion" scores were (0,10;p=0.001), "Ease of Use" (5,9;p=0.002), "Accuracy" (7,9;p=0.002), "Technology Advancement" (4,10;p=0.001), and "Interest" (3,10;p=0.002). Conclusions: Holo-Stroke-CTA resulted in higher reliability and satisfaction vs. standard DICOM tele-stroke tele-radiology. Providers noted the ability to see 3D vessels in virtual space, vs. scrolling through axial/sagittal/coronal images, resulted in higher accuracy. Even for trainees and difficult to assess vessels, providers were more able to identify LVOs using Holo-Stroke-CTA. Providers were enthusiastic for the immersive radiology assessment, with the ability to immersively resize, rotate, and investigate hologram in 3D virtual space. Though further assessments are needed, Holo-Stroke-CTA can help providers more easily, and at-a-glance, evaluate CTA for LVO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.